55 results
8-K
EX-99.1
AUPH
Aurinia Pharmaceuticals Inc
10 May 22
Aurinia Reports First Quarter 2022 Financial and Operational Results
6:06am
on assumptions regarding the impact of COVID-19 on the current business environment and represents an increase of more than 150 to 200% in net revenue from sales
8-K
EX-99.1
wpj0xb
28 Feb 22
Aurinia Reports Fourth Quarter and Full Year 2021 Financial Results and Company Updates
6:08am
S-3ASR
EX-1.2
zvr4jt
19 Nov 21
Automatic shelf registration
5:04pm
S-3ASR
zdt tp3wdkkfqxk2hb
19 Nov 21
Automatic shelf registration
5:04pm
DEF 14A
obw4vhduddfi
10 May 21
Definitive proxy
4:06pm
PRE 14A
4b2 vr6it4
27 Apr 21
Preliminary proxy
4:32pm
10-K
EX-10.6
04gppi9
24 Feb 21
Annual report
4:09pm
10-K
EX-10.7
r08jprjo6mce 45
24 Feb 21
Annual report
4:09pm
10-K
EX-10.17
ahzuuxpbx1fb3
24 Feb 21
Annual report
4:09pm
10-K
EX-10.8
45qy sgqh30uhluh1
24 Feb 21
Annual report
4:09pm
10-K
ycs3k41kt
24 Feb 21
Annual report
4:09pm
6-K
EX-99.2
mizbm shj8w2bbvdgv
30 Dec 20
Material Change Report
5:30pm
6-K
EX-99.1
hqbubjjhp0t
16 Dec 20
Aurinia Pharmaceuticals Inc. 6-K
12:00am
6-K
EX-99.2
gnpgv9hi
10 Nov 20
Current report (foreign)
4:05pm
6-K
EX-99.2
cs3gk
11 Aug 20
Current report (foreign)
4:04pm